跳至主要内容
临床试验/KCT0001926
KCT0001926已完成未知

Balanced deep sedation using etomidate versus propofol based on midazolam by nurses under supervision of endoscopists during endoscopic retrograde cholangiopancreatography: A prospective double-blinded randomized controlled trial

Hallym University Medical Center-Dongtan0 个研究点目标入组 128 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
128

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
20(Year) 至 80(Year)(—)
性别
All

入选标准

  • Age: 20–80 years
  • Needs for endoscopic retrograde cholangiopancreatography
  • American Society of Anesthesiologists (ASA) physical status I–II

排除标准

  • 1. a history of adverse events with prior sedation
  • 2. known hypersensitivity to egg products, soy beans, etomidate, propofol, or its emulsifier
  • 3. known adrenocortical insufficiency, chronic corticoid therapy, or porphyria
  • 4. severe renal failure (serum creatinine level >2 mg/dl)
  • 5. pregnant or breast-feeding
  • 6. desire to have endoscopy without sedation
  • 7. unable to provide informed consent
  • 8. baseline mean blood pressure (MBP) <60 mmHg
  • 9. baseline oxygen saturation (SpO2) <90% in room air or <95% with 2 L/min oxygen

研究者

发起方
Hallym University Medical Center-Dongtan

相似试验